Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong · Delayed Price · Currency is HKD 27.58
-2.02 (-6.82%)
Aug 21, 2026, 4:08 PM HKT
Giant Biogene Holding Revenue
Giant Biogene Holding had revenue of 2.92B CNY in the half year ending June 30, 2026, with 14.85% growth. This brings the company's revenue in the last twelve months to 5.32B, down -12.89% year-over-year. In the year 2025, Giant Biogene Holding had annual revenue of 5.52B, down -0.37%.
Revenue (ttm)
5.32B CNY
Revenue Growth
-12.89%
P/S Ratio
4.76
Revenue / Employee
2.42M CNY
Employees
2,201
Market Cap
29.28B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.52B | -20.30M | -0.37% |
| Dec 31, 2024 | 5.54B | 2.01B | 57.17% |
| Dec 31, 2023 | 3.52B | 1.16B | 49.05% |
| Dec 31, 2022 | 2.36B | 811.96M | 52.30% |
| Dec 31, 2021 | 1.55B | 362.01M | 30.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Hengan International Group Company | 25.80B |
| Shanghai Chicmax Cosmetic | 10.21B |
| Blue Moon Group Holdings | 8.25B |
| Mao Geping Cosmetics | 5.62B |
| Softcare | 4.42B |
| Shanghai Forest Cabin Cosmetics Group | 2.73B |
| Eternal Beauty Holdings | 2.45B |
| Cheerwin Group | 2.21B |
Giant Biogene Holding News
- 5 days ago - Giant Biogene Holding Earnings release: H1 2026 - Filings
- 5 months ago - Giant Biogene Holding Earnings release: H2 2025 - Filings
- 5 months ago - Giant Biogene Holding Annual report: H2 2025 - Filings
- 1 year ago - Giant Biogene Holding Quarterly report: H1 2025 - Filings
- 1 year ago - Giant Biogene Holding Earnings release: H1 2025 - Filings
- 1 year ago - Giant Biogene Bruised In A 'Battle Of The Skincare Belles' - Benzinga